Andrew R. Boll
Overview
Andrew R. Boll received an average of $920K in total compensation, including $265K in salary, at Imprimis Pharmaceuticals from 2012 to 2022.
2022Imprimis PharmaceuticalsChief Financial Officer and Corporate Secretary
2021Imprimis PharmaceuticalsChief Financial Officer and Corporate Secretary
2020Imprimis PharmaceuticalsChief Financial Officer
2019Imprimis PharmaceuticalsChief Financial Officer
2018Imprimis PharmaceuticalsChief Financial Officer
2017Imprimis PharmaceuticalsChief Financial Officer
2016Imprimis PharmaceuticalsChief Financial Officer
2015Imprimis PharmaceuticalsChief Financial Officer
2014Imprimis PharmaceuticalsChief Financial Officer
2013Imprimis PharmaceuticalsChief Financial Officer
Source: SEC filings on April 28, 2023, April 26, 2022, April 23, 2021, April 24, 2020, April 25, 2019, April 30, 2018, April 27, 2017, April 10, 2015, and July 17, 2013.
Related executives
We found six more executives who work or worked at Imprimis Pharmaceuticals.
Mark Baum
Imprimis Pharmaceuticals
Chief Executive Officer
John Saharek
Imprimis Pharmaceuticals
Chief Commercial Officer and President, ImprimisRx
Balbir Brar
Imprimis Pharmaceuticals
Former President
Joachim Schupp
Imprimis Pharmaceuticals
Chief Medical Officer
Juliet Singh
Imprimis Pharmaceuticals
Chief Executive Officer
John Lomoro
Imprimis Pharmaceuticals
Chief Financial Officer
News
Imprimis Pharmaceuticals CEO Mark Baum's 2022 pay falls 84% to $1.2M
April 28, 2023
Imprimis Pharmaceuticals CEO Mark Baum's 2021 pay jumps 195% to $7.3M
April 26, 2022
Imprimis Pharmaceuticals CEO Mark Baum's 2020 pay jumps 80% to $2.5M
April 23, 2021
Imprimis Pharmaceuticals CEO Mark Baum's 2019 pay jumps 30% to $1.4M
April 24, 2020
Imprimis Pharmaceuticals CEO Mark Baum's 2018 pay rises 16% to $1.1M
April 25, 2019